Download PDF
J Knee Surg 2022; 35(09): 997-1003
DOI: 10.1055/s-0040-1721414
Original Article

Blood Management in Total Knee Arthroplasty: A Nationwide Analysis from 2011 to 2018

Jared A. Warren
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
John P. McLaughlin
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Robert M. Molloy
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Carlos A. Higuera
2   Department of Orthopedic Surgery, Cleveland Clinic Florida, Weston, Florida
,
Jonathan L. Schaffer
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Nicolas S. Piuzzi 
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Both advances in perioperative blood management, anesthesia, and surgical technique have improved transfusion rates following primary total knee arthroplasty (TKA), and have driven substantial change in preoperative blood ordering protocols. Therefore, blood management in TKA has seen substantial changes with the implementation of preoperative screening, patient optimization, and intra- and postoperative advances. Thus, the purpose of this study was to examine changes in blood management in primary TKA, a nationwide sample, to assess gaps and opportunities. The American College of Surgeons National Surgical Quality Improvement Program database was used to identify TKA (n = 337,160) cases from 2011 to 2018. The following variables examined, such as preoperative hematocrit (HCT), anemia (HCT <35.5% for females and <38.5% for males), platelet count, thrombocytopenia (platelet count < 150,000/µL), international normalized ration (INR), INR > 2.0, bleeding disorders, preoperative, and postoperative transfusions. Analysis of variances were used to examine changes in continuous variables, and Chi-squared tests were used for categorical variables. There was a substantial decrease in postoperative transfusions from high of 18.3% in 2011 to a low of 1.0% in 2018, (p < 0.001), as well as in preoperative anemia from a high of 13.3% in 2011 to a low of 9.5% in 2016 to 2017 (p < 0.001). There were statistically significant, but clinically irrelevant changes in the other variables examined. There was a HCT high of 41.2 in 2016 and a low of 40.4 in 2011 to 2012 (p < 0.001). There was platelet count high of 247,400 in 2018 and a low of 242,700 in 201 (p < 0.001). There was a high incidence of thrombocytopenia of 5.2% in 2017 and a low of low of 4.4% in 2018 (p < 0.001). There was a high INR of 1.037 in 2011 and a low of 1.021 in 2013 (p < 0.001). There was a high incidence of INR >2.0 of 1.0% in 2012 to 2015 and a low of 0.8% in 2016 to 2018 (p = 0.027). There was a high incidence of bleeding disorders of 2.9% in 2013 and a low of 1.8% in 2017 to 2018 (p < 0.001). There was a high incidence of preoperative transfusions of 0.1% in 2011 to 2014 and a low of <0.1% in 2015 to 2018 (p = 0.021). From 2011 to 2018, there has been substantial decreases in patients receiving postoperative transfusions after primary TKA. Similarly, although a decrease in patients with anemia was seen, there remains 1 out 10 patients with preoperative anemia, highlighting the opportunity to further improve and address this potentially modifiable risk factor before surgery. These findings may reflect changes during TKA patient selection, optimization, or management, and emphasizes the need to further advance multimodal approaches for perioperative blood management of TKA patients. This is a Level III study.

Keywords

Blood Management - transfusion - anemia - knee - total knee arthroplasty


Publication History

Received: 08 August 2020

Accepted: 17 October 2020

Article published online:
25 November 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Cundy WJ, Theodoulou A, Ling CM, Krishnan J, Wilson CJ. Blood loss in total knee arthroplasty. J Knee Surg 2017; 30 (05) 452-459
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Keating EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 1998; 357 (357) 50-59
    CrossrefPubMedGoogle Scholar
  • 3 Schwab PE, Lavand'homme P, Yombi JC, Thienpont E. Lower blood loss after unicompartmental than total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2015; 23 (12) 3494-3500
    CrossrefPubMedGoogle Scholar
  • 4 Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am 2013; 95 (19) 1777-1783
    CrossrefPubMedGoogle Scholar
  • 5 Hushmendy SF, Cushner FD. Avoiding complications associated with anemia following total joint arthroplasty. Tech Orthop 2019; 34 (03) 146-154
    CrossrefPubMedGoogle Scholar
  • 6 Salt E, Wiggins AT, Rayens MK. et al. Risk factors for transfusions following total joint arthroplasty in patients with rheumatoid arthritis. J Clin Rheumatol 2018; 24 (08) 422-426
    CrossrefPubMedGoogle Scholar
  • 7 Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113 (02) 482-495
    CrossrefPubMedGoogle Scholar
  • 8 Malpani R, Haynes MS, Clark MG, Galivanche AR, Bovonratwet P, Grauer JN. Abnormally high, as well as low, preoperative platelet counts correlate with adverse outcomes and readmissions after elective total knee arthroplasty. J Arthroplasty 2019; 34 (08) 1670-1676
    CrossrefPubMedGoogle Scholar
  • 9 Rudasill SE, Liu J, Kamath AF. Revisiting the international normalized ratio (INR) threshold for complications in primary total knee arthroplasty: an analysis of 21,239 cases. J Bone Joint Surg Am 2019; 101 (06) 514-522
    CrossrefPubMedGoogle Scholar
  • 10 Bedair H, Yang J, Dwyer MK, McCarthy JC. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective. Clin Orthop Relat Res 2015; 473 (02) 590-596
    CrossrefPubMedGoogle Scholar
  • 11 Mundy GM, Birtwistle SJ, Power RA. The effect of iron supplementation on the level of haemoglobin after lower limb arthroplasty. J Bone Joint Surg Br 2005; 87 (02) 213-217
    CrossrefPubMedGoogle Scholar
  • 12 Petis SM, Lanting BA, Vasarhelyi EM, Naudie DDR, Ralley FE, Howard JL. Is There a role for preoperative iron supplementation in patients preparing for a total hip or total knee arthroplasty?. J Arthroplasty 2017; 32 (09) 2688-2693
    CrossrefPubMedGoogle Scholar
  • 13 Cai DF, Fan QH, Zhong HH, Peng S, Song H. The effects of tourniquet use on blood loss in primary total knee arthroplasty for patients with osteoarthritis: a meta-analysis. J Orthop Surg Res 2019; 14 (01) 348
    CrossrefPubMedGoogle Scholar
  • 14 Shen WS, Li DS, Shao J, Lou J, Chen QS. The reinfusion of autogenous shed blood after unilateral total knee arthroplasty using the perioperative autologous transfusion system orthopat. Am J Ther 2016; 23 (06) e1623-e1629
    CrossrefPubMedGoogle Scholar
  • 15 Cip J, Widemschek M, Benesch T, Waibel R, Martin A. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial. Clin Orthop Relat Res 2013; 471 (04) 1319-1325
    CrossrefPubMedGoogle Scholar
  • 16 Box HN, Huo MH. Reducing blood loss, decreasing transfusion rates, and postoperative venous thromboembolism prophylaxis in total hip arthroplasty. Curr Orthop Pract 2017; 28 (03) 244-248
    CrossrefPubMedGoogle Scholar
  • 17 Gianakos AL, Hurley ET, Haring RS, Yoon RS, Liporace FA. Reduction of blood loss by tranexamic acid following total hip and knee arthroplasty: a meta-analysis. JBJS Rev 2018; 6 (05) e1
    CrossrefPubMedGoogle Scholar
  • 18 Fillingham YA, Ramkumar DB, Jevsevar DS. et al. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the american association of hip and knee surgeons, american society of regional anesthesia and pain medicine, american academy of orthopaedic surgeons, hip society, and knee society. J Arthroplasty 2018; 33 (10) 3065-3069
    CrossrefPubMedGoogle Scholar
  • 19 Kurian DJ, Guinn NR, Hunting J. et al. Preoperative blood management strategy for elective hip and knee arthroplasty. J Healthc Qual 2019; 41 (06) 376-383
    CrossrefPubMedGoogle Scholar
  • 20 Loftus TJ, Spratling L, Stone BA, Xiao L, Jacofsky DJ. A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes. J Arthroplasty 2016; 31 (01) 11-14
    CrossrefPubMedGoogle Scholar
  • 21 Zhang S, Huang Q, Xu B, Ma J, Cao G, Pei F. Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study. Medicine (Baltimore) 2018; 97 (01) e9429
    CrossrefPubMedGoogle Scholar
  • 22 NSQIP, American College of Surgeons National Surgical Quality Improvement Program. Accessed 2018 at: https://www.facs.org/quality-programs/acs-nsqip
    PubMed
  • 23 Billett HH. Hemoglobin and Hematocrit. Clin Methods Hist Phys Lab Exam.. 1990; DOI: 10.1055/s-2004-821156.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Lee EJ, Lee AI. Thrombocytopenia. Prim Care 2016; 43 (04) 543-557
    CrossrefPubMedGoogle Scholar
  • 25 Nishimura RA, Otto CM, Bonow RO. et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63 (22) 2438-2488
    CrossrefPubMedGoogle Scholar
  • 26 Warner MA, Shore-Lesserson L, Shander A, Patel SY, Perelman SI, Guinn NR. Perioperative anemia: Prevention, diagnosis, and management throughout the spectrum of perioperative care. Anesth Analg 2020; 130 (05) 1364-1380
    CrossrefPubMedGoogle Scholar
  • 27 Holt JB, Miller BJ, Callaghan JJ, Clark CR, Willenborg MD, Noiseux NO. Minimizing blood transfusion in total hip and knee arthroplasty through a multimodal approach. J Arthroplasty 2016; 31 (02) 378-382
    CrossrefPubMedGoogle Scholar
  • 28 Kopanidis P, Hardidge A, McNicol L, Tay S, McCall P, Weinberg L. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty. J Orthop Surg Res 2016; 11 (01) 28
    CrossrefPubMedGoogle Scholar
  • 29 Humbyrd CJ. The ethics of bundled payments in total joint replacement: “cherry picking” and “lemon dropping.”. J Clin Ethics 2018
    PubMedGoogle Scholar
  • 30 Wang Y, Beydoun MA. The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6-28
    CrossrefPubMedGoogle Scholar
  • 31 Ibrahim SA. Racial variations in the utilization of knee and hip joint replacement: an introduction and review of the most recent literature. Curr Orthop Pract 2010; 21 (02) 126-131
    CrossrefPubMedGoogle Scholar
  • 32 Zakai NA, McClure LA, Prineas R. et al. Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol 2009; 169 (03) 355-364
    CrossrefPubMedGoogle Scholar
  • 33 Hooper J, Schwarzkopf R. Additional tools to prevent blood loss in total joint arthroplasty. Tech Orthop 2017; 32 (01) 34-40
    CrossrefPubMedGoogle Scholar
  • 34 Kimball CC, Nichols CI, Vose JG. Blood transfusion trends in primary and revision total joint arthroplasty: recent declines are not shared equally. J Am Acad Orthop Surg 2019; 27 (20) e920-e927
    CrossrefPubMedGoogle Scholar